// App-Quantinova.ai

2184 : Biomarkers Of Complement and Endothelial Activation, Inflammation, Thrombosis and Renal Injury In Patients (pts) With aHUS Treated With Eculizumab (ECU)

Researchers

Presenter

  • Roxanne Cofiell

Principal Investigators

  • Anjli Kukreja

  • Krystin Bedard

  • Yan Yan

  • Angela Mickle

  • Masayo Ogawa

  • Camille L. Bedrosian

  • Susan Faas

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Alexion Pharmaceutic

Study Components

Therapeutic Area

  • Nephrology

  • Blood/haematological Diseases

Disease

  • Thrombotic microangiopathy

  • Acute renal failure

  • Venous thrombosis

  • Atypical hemolytic uremic syndrome

Biomarkers

  • C-X-C motif chemokine 10

  • D-dimer

  • Interleukin 6

  • Lactate dehydrogenase

  • Vascular cell adhesion molecule 1

Drug/Treatment

  • Thrombomodulin alfa

  • Eculizumab

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved